Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,602 public trials 545 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.

NCT00388635

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Clínic Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital Germans Trias i Pujol Barcelona, Spain
  • Hospital Universitario de Canarias Santa Cruz de Tenerife, Canary Islands, Spain
View all 19 locations
View Trial Details
Completed

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

NCT00361049

Conditions
Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +84 more
Locations
  • Geauga Regional Hospital Cleveland, Ohio, United States
  • Lake/University Ireland Cancer Center Cleveland, Ohio, United States
  • Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • University Suburban Health Center Cleveland, Ohio, United States
View Trial Details
Completed

Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma

NCT01233895

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Sanofi-Aventis Investigational Site Number 250002 Lille, France
  • Sanofi-Aventis Investigational Site Number 250001 Nantes, France
  • Sanofi-Aventis Investigational Site Number 250003 Vandœuvre-lès-Nancy, France
  • Sanofi-Aventis Investigational Site Number 380001 Torino, Italy
View Trial Details

Related conditions